Filing Details
- Accession Number:
- 0001368148-21-000072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-15 17:48:05
- Reporting Period:
- 2021-06-11
- Accepted Time:
- 2021-06-15 17:48:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1368148 | Athersys Inc / New | ATHX | Pharmaceutical Preparations (2834) | 204864095 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402610 | J John Harrington | 3201 Carnegie Avenue Cleveland OH 44115-2634 | Exec Vice Pres And Cso | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-11 | 133,333 | $0.00 | 805,728 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2021-06-15 | 20,767 | $1.55 | 784,961 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to purchase) | Acquisiton | 2021-06-11 | 300,000 | $0.00 | 300,000 | $1.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 300,000 | 2031-06-11 | No | 4 | A | Direct |
Footnotes
- Award of annual restricted stock units, each of which represent a contingent right to receive one share of Athersys, Inc. common stock after vesting. The restricted stock units vest ratably on a quarterly basis over a four-year period.
- Shares sold pursuant to a predefined Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.535 to $1.57, inclusive, in accordance with a previously established Rule 10b5-1 trading plan.
- Securities beneficially owned are comprised of (1) 486,372 shares of common stock owned and (2) unvested restricted stock units aggregating 298,589 related to annual awards, which vest quarterly over a three or four-year period from date of grant.
- Award of an annual stock option. The option vests ratably on a quarterly basis over a four-year period.
Billionaire Hedge Funds
